Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_assertion type Assertion NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_head.
- NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_assertion description "[In previous studies we demonstrated that antisense oligonucleotides (oligos) against transforming growth factor-alpha (TGF-alpha [MR1]), its binding site the epidermal growth factor receptor (EGFR [MR2]), and the anti-apoptosis protein bcl-2 (MR4) are efficacious against prostate tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_provenance.
- NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_assertion evidence source_evidence_literature NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_provenance.
- NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_assertion SIO_000772 17917084 NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_provenance.
- NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_assertion wasDerivedFrom befree-20150227 NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_provenance.
- NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_assertion wasGeneratedBy ECO_0000203 NP369013.RAXCf6vOSypKaOacsJMP7IFKqFfjot1ZGOtHPpNaXF03E130_provenance.